Stocks

The table gives an overview of all stocks, alphabetically sorted.
 C Security CSEC Feb 19, 2020 0.30 +1.33   
 C-RAD B CRADB Feb 19, 2020 46.70 +0.43   
 CAG Group CAG Feb 19, 2020 68.00 -4.23   
 Calliditas Therapeutics CALTX Feb 19, 2020 114.40 0.00   
 Calmark B CALMAB Feb 19, 2020 6.85 +11.38   
 Camanio Care CARE Feb 19, 2020 0.26 +3.66   
 Camurus CAMX Feb 19, 2020 107.60 -2.00   
 Cantargia CANTA Feb 19, 2020 24.00 -1.64   
 Capacent Holding CAPAC Feb 19, 2020 37.40 -2.35   
 Carbiotix CRBX Feb 19, 2020 6.12 +5.52   
 Castellum CAST Feb 19, 2020 254.70 +2.70   
 Catella A CATA Feb 19, 2020 32.40 -3.57   
 Catella B CATB Feb 19, 2020 33.00 -0.45   
 Catena CATE Feb 19, 2020 438.50 +3.54   
 Catena Media CTM Feb 19, 2020 28.92 -0.96   
 Cavotec SA CCC Feb 19, 2020 22.30 +9.31   
 Cell Impact B CIB Feb 19, 2020 27.30 +18.18   
 CellaVision CEVI Feb 19, 2020 319.00 -0.47   
 CELLINK B CLNKB Feb 19, 2020 107.00 +2.69   
 Cereno Scientific B CRNOB Feb 19, 2020 3.30 -1.20   
 CGit B CGITB Feb 19, 2020 66.00 +3.94   
 Challenger Mobile B CHALB Feb 19, 2020 0.05 +4.17   
 Chordate Medical Holding CMH Feb 19, 2020 1.00 0.00   
 Christian Berner Tech Trade B CBTTB Feb 19, 2020 29.20 +0.34   
 ChromoGenics CHRO Feb 19, 2020 0.29 -5.56   
 Cibus Nordic Real Estate CIBUS Feb 19, 2020 162.50 +2.85   
 Clas Ohlson B CLASB Feb 19, 2020 109.90 -0.18   
 Clavister Holding CLAV Feb 19, 2020 15.05 -2.90   
 Clean Motion CLEMO Feb 19, 2020 1.86 -4.87   
 Clemondo Group CLEM Feb 19, 2020 0.85 -5.03   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK